Protease XIV abolishes NHE inhibition by empagliflozin in cardiac cells

Protease XIV abolishes NHE inhibition by empagliflozin in cardiac cells

Background: SGLT2i directly inhibit the cardiac sodium-hydrogen exchanger-1 (NHE1) in isolated ventricular cardiomyocytes (CMs). However, other studies with SGLT2i have yielded conflicting results. This may be explained by methodological factors including cell isolation techniques, cell types and am...

Full description

Bibliographic Details
Main Authors: Sha Chen, Cees A. Schumacher, Shirley C. M. Van Amersfoorth, Jan W. T. Fiolet, Antonius Baartscheer, Marieke W. Veldkamp, Ruben Coronel, Coert J. Zuurbier
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-07-01
Series:Frontiers in Physiology
Subjects:
SGLT2
NHE
protease XIV
empagliflozin
cardiomyocyte
Online Access:https://www.frontiersin.org/articles/10.3389/fphys.2023.1179131/full

Internet

https://www.frontiersin.org/articles/10.3389/fphys.2023.1179131/full

Similar Items